These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28587351)

  • 1. Role of RANK and Akt1 activation in human osteosarcoma progression: A clinicopathological study.
    Zhu J; Liu Y; Zhu Y; Zeng M; Xie J; Lei P; Li K; Hu Y
    Exp Ther Med; 2017 Jun; 13(6):2862-2866. PubMed ID: 28587351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.
    Bago-Horvath Z; Schmid K; Rössler F; Nagy-Bojarszky K; Funovics P; Sulzbacher I
    Pathology; 2014 Aug; 46(5):411-5. PubMed ID: 24842377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma.
    Trieb K; Windhager R
    Oncol Lett; 2015 Sep; 10(3):1813-1815. PubMed ID: 26622756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
    Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
    J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANK and RANK ligand expression in primary human osteosarcoma.
    Branstetter D; Rohrbach K; Huang LY; Soriano R; Tometsko M; Blake M; Jacob AP; Dougall WC
    J Bone Oncol; 2015 Sep; 4(3):59-68. PubMed ID: 27556008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
    Mori K; Berreur M; Blanchard F; Chevalier C; Guisle-Marsollier I; Masson M; Rédini F; Heymann D
    Oncol Rep; 2007 Dec; 18(6):1365-71. PubMed ID: 17982618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
    Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
    Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.
    Do SI; Jung WW; Kim HS; Park YK
    Int J Oncol; 2009 Mar; 34(3):797-803. PubMed ID: 19212684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling.
    Golden D; Saria EA; Hansen MF
    J Cell Physiol; 2015 Dec; 230(12):2951-60. PubMed ID: 25893522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis.
    Abd El-Rehim DM; Osman NA
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):1-9. PubMed ID: 25481287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases.
    Navet B; Ando K; Vargas-Franco JW; Brion R; Amiaud J; Mori K; Yagita H; Mueller CG; Verrecchia F; Dumars C; Heymann MF; Heymann D; Lézot F
    Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30355966
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
    Liu Z; Zhang G; Zhao C; Li J
    Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
    Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
    Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
    Liu J; Cheng Sun SH; Sun SJ; Huang C; Hu HH; Jin YB; Qiu ZJ
    Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.